Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, Share, Revenue, Trends And Drivers For 2024-2033

LONDON, GREATER LONDON, UK, December 19, 2023 /EINPresswire.com/ -- Year End Offer By The Business Research Company - Get 33% Discount On Opportunities And Strategies Reports And 25% Discount On Global Market Reports

The Business Research Company’s “Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report 2024 is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the chemotherapy-induced nausea and vomiting (cinv) market size is predicted to reach the chemotherapy-induced nausea and vomiting (cinv) market size has grown strongly in recent years. It will grow from $2.69 billion in 2023 to $2.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growth in chemotherapy use, improved antiemetic agents, clinical guidelines, patient advocacy.The chemotherapy-induced nausea and vomiting (cinv) market size is expected to see strong growth in the next few years. It will grow to $3.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%.

The growth in the chemotherapy-induced nausea and vomiting (cinv) market is due to the increasing prevalence of cancer. North America region is expected to hold the largest chemotherapy-induced nausea and vomiting (cinv) market share. Major players in the chemotherapy-induced nausea and vomiting (cinv) market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Baxter International Inc., Teva Pharmaceuticals Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals PLC.

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segments
•By Form: Injectables, Oral, Transdermal Patches
•By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class
•By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)
•By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores
•By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications
•By Geography: The global chemotherapy-induced nausea and vomiting (cinv) market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=13031&type=smp

Chemotherapy-induced nausea and vomiting (CINV) is a condition that causes nausea and vomiting sensation, which can develop due to chemotherapy treatment. It is a prevalent side-effect affecting many cancer patients, affecting their quality of life and treatment results. CINV can be managed and treated through medications and lifestyle changes.

Read More On The Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report At:
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-nausea-and-vomiting-cinv-global-market-report

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Characteristics
3. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends And Strategies
4. Chemotherapy-Induced Nausea and Vomiting (CINV) Market – Macro Economic Scenario
5. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size And Growth
……
27. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Future Outlook and Potential Analysis
30. Appendix

Browse Through More Similar Reports By The Business Research Company:

Cancer Clinical Decision Tools Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Cancer biologics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Chemotherapy-Induced Anemia Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube